FDA's PCCP guidance for AI devices, and the lifecycle draft
FDA's final PCCP guidance for AI-enabled device software was posted on 3 December 2024. The broader AI lifecycle guidance is still a January 2025 draft.
- US
1The AI-specific PCCP final guidance was posted on 3 December 2024; the document is dated 4 December 2024. An 'August 2025' date seen in some sources is not the issue date.
2A PCCP describes in advance which changes a manufacturer will make to an AI device and how it will validate them, so updates need not each go back to FDA.
3The January 2025 draft guidance on AI-enabled device software lifecycle management is still a draft as of October 2026.
4FDA's device center lists finalising that lifecycle guidance as a top priority on its FY2027 agenda, and a draft guidance on generative-AI mental-health devices is also listed but not yet issued.
Limits of this page. FDA's guidance PDFs were not machine-readable when reviewed. The December 2024 date comes from FDA's own roundup page and a search extract of the guidance text. An FDA page we opened carried an 'August 2025' currency stamp that we could not explain; it may be a page-update date or a different guidance. The FY2027 agenda item comes from a trade-press report, not FDA's agenda page.
What does FDA’s PCCP guidance for AI-enabled devices say?
It describes what a manufacturer should put in a predetermined change control plan: the modifications planned, the way each will be developed and validated, and an assessment of the impact. FDA’s roundup says the final guidance was posted on 3 December 2024, and the document gives 4 December 2024 as its original issue date.
Why does the date matter?
Some sources say “August 2025” for this guidance. Our verification found that is not its issue date. An FDA page for the guidance shows an August 2025 currency stamp, which may reflect a page update or a separate, broader device PCCP guidance. Cite December 2024 and link FDA’s page.
Is the AI lifecycle guidance final?
No. The draft titled “Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations” was issued in January 2025. Trade press reported on 2 October 2026 that FDA’s device center lists finalising it as a priority on its FY2027 agenda. The same report lists a draft guidance on generative-AI conversational devices for mental-health disorders as planned but not yet issued.
| Item | Status as of 15 November 2026 |
|---|---|
| PCCP for AI-enabled device software functions | Final, posted 3 December 2024 |
| AI-enabled device software lifecycle guidance | Draft (January 2025); FY2027 priority |
| Generative-AI mental-health device guidance | Listed for FY2027; not issued |
| Revised CDS guidance | Final, 6 January 2026 |
What does this mean for evaluation evidence?
A change plan is only as good as its validation method. Teams that update models, prompts or speech recognisers need a repeatable test suite and a record of results before and after each change. See the CDS guidance for the other FDA document in this area.
What did we not verify?
We did not read the FDA guidance text and cannot say how the framework applies to prompt or model swaps in LLM products. That question needs regulatory counsel.
Frequently asked questions
What is a predetermined change control plan?
A PCCP is a plan, submitted with a device application, that describes the specific modifications a manufacturer intends to make to an AI-enabled device and the methods it will use to validate them. If FDA authorises the plan, those defined changes can be made without a new submission each time.
Does a PCCP apply to a large language model that gets updated by its provider?
Whether the PCCP framework applies to prompt or model swaps in a specific product is not something we could verify. It applies to AI-enabled device software functions that are devices. Most ambient scribes are described as administrative tools, so check with counsel.
Is the AI lifecycle guidance final?
No. The January 2025 draft on AI-enabled device software functions: lifecycle management and marketing submission recommendations was still a draft as of October 2026, and trade press reports FDA lists finalising it as an FY2027 priority.
Sources
- FDA Roundup: December 3, 2024U.S. Food and Drug Administration · 2024-12-03
- FDA finalizes PCCP guidance for AI-enabled medical devicesAkin Gump · 2024-12
- FDA's device center releases guidance agenda for FY 2027RAPS · 2026-10-02
Found something out of date? Write to hello@precision.example and we will fix it.